Advances in our understanding of diabetic retinopathy

Clinical Science

Volumn 125, Issue 1, 2013, Pages 1-17

  Stitt, Alan W ^a   Lois, Noemi ^a   Medina, Reinhold J ^a   Adamson, Peter ^b   Curtis, Timothy M ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Diabetes; Diabetic retinopathy; Retina; Visual loss

Indexed keywords

ACETAZOLAMIDE; BEVACIZUMAB; BRADYKININ ANTAGONIST; CORTICOSTEROID; DEXAMETHASONE; FENOFIBRATE; FLUOCINOLONE; RANIBIZUMAB; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; RECOMBINANT VASCULOTROPIN; SIMVASTATIN; TRIAMCINOLONE; VASCULOTROPIN;

BLOOD PRESSURE REGULATION; CATARACT; CELL THERAPY; CLINICAL FEATURE; COST EFFECTIVENESS ANALYSIS; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DRUG EFFICACY; ENDOTHELIAL PROGENITOR CELL; GENETIC LINKAGE; GLAUCOMA; GLIA; GLYCEMIC CONTROL; HISTOPATHOLOGY; HUMAN; INFLAMMATION; INTRAOCULAR PRESSURE; KERATOPATHY; LASER COAGULATION; LOW DRUG DOSE; NERVE CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REGENERATIVE MEDICINE; RETINA BLOOD FLOW; RETINA BLOOD VESSEL; RETINA DEGENERATION; REVIEW; RISK FACTOR; SIDE EFFECT; SMOKING CESSATION;

ANIMALS; DIABETIC RETINOPATHY; HUMANS; REGENERATIVE MEDICINE; RETINA; RISK FACTORS;

EID: 84875586101     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20120588     Document Type: Review

References (203)

1. Rathmann, W. and Giani, G. (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27, 2568-2569
2. Derakhshan, R., Arababadi, M. K., Ahmadi, Z., Karimabad, M. N., Salehabadi, V. A., Abedinzadeh, M., Khorramdelazad, H., Balaei, P., Kennedy, D. and Hassanshahi, G. (2012) Increased circulating levels of SDF-1 (CXCL12) in type 2 diabetic patients are correlated to disease state but are unrelated to polymorphism of the SDF-1beta gene in the Iranian population. Inflammation 35, 900-904
3. Lam, D. W. and LeRoith, D. (2012) The worldwide diabetes epidemic. Curr. Opin. Endocrinol. Diabetes Obes. 19, 93-96
4. Holman, N., Forouhi, N. G., Goyder, E. and Wild, S. H. (2011) The Association of Public Health Observatories (APHO) Diabetes Prevalence Model: estimates of total diabetes prevalence for England, 2010-2030. Diabetic Med. 28, 575-582
5. Klein, R., Klein, B. E. and Moss, S. E. (1989) The Wisconsin epidemiological study of diabetic retinopathy: a review. Diabetes Metab. Rev. 5, 559-570
6. Romero-Aroca, P., Sagarra-Alamo, R., Basora-Gallisa, J., Basora-Gallisa, T., Baget-Bernaldiz, M. and Bautista-Perez, A. (2010) Prospective comparison of two methods of screening for diabetic retinopathy by nonmydriatic fundus camera. Clin. Ophthalmol. 4, 1481-1488
7. Resnikoff, S., Pascolini, D., Etya'ale, D., Kocur, I., Pararajasegaram, R., Pokharel, G. P. and Mariotti, S. P. (2004) Global data on visual impairment in the year 2002. Bull.World Health Organ. 82, 844-851
8. Yau, J. W., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S. J., Dekker, J. M., Fletcher, A., Grauslund, J. et al. (2012) Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35, 556-564
9. Minassian, D. C., Owens, D. R. and Reidy, A. (2012) Prevalence of diabetic macular oedema and related health and social care resource use in England. Br. J. Ophthalmol. 96, 345-349
10. Jones, S. and Edwards, R. T. (2010) Diabetic retinopathy screening: a systematic review of the economic evidence. Diabetic Med. 27, 249-256
11. Klein, R., Klein, B. E., Moss, S. E., Davis, M. D. and DeMets, D. L. (1984) The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch. Ophthalmol. 102, 520-526
12. Early Treatment Diabetic Retinopathy Study Research Group (1991) Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology 98, 766-785
13. Joussen, A. M., Smyth, N. and Niessen, C. (2007) Pathophysiology of diabetic macular edema. Dev.Ophthalmol. 39, 1-12
14. Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329, 977-986
15. UK Prospective Diabetes Study Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352, 854-865
16. The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2003) Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA, J. Am. Med. Assoc. 290, 2159-2167
17. Engerman, R. L. and Kern, T. S. (1987) Progression of incipient diabetic retinopathy during good glycemic control. Diabetes 36, 808-812
18. van Leiden, H. A., Dekker, J. M., Moll, A. C., Nijpels, G., Heine, R. J., Bouter, L. M., Stehouwer, C. D. and Polak, B. C. (2002) Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study. Diabetes Care 25, 1320-1325
19. Keech, A., Simes, R. J., Barter, P., Best, J., Scott, R., Taskinen, M. R., Forder, P., Pillai, A., Davis, T., Glasziou, P. et al. (2005) Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 366, 1849-1861
20. Ismail-Beigi, F., Craven, T., Banerji, M. A., Basile, J., Calles, J., Cohen, R. M., Cuddihy, R., Cushman, W. C., Genuth, S., Grimm, R. H. et al. (2010) Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 376, 419-430
21. Sen, K., Misra, A., Kumar, A. and Pandey, R. M. (2002) Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia. Diabetes Res. Clin. Pract. 56, 1-11
22. Wong, T. Y., Simo, R. and Mitchell, P. (2012) Fenofibrate: a potential systemic treatment for diabetic retinopathy? Am. J. Ophthalmol 154, 6-12
23. UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br. Med. J. 317, 703-713
24. Chaturvedi, N., Sjolie, A. K., Stephenson, J. M., Abrahamian, H., Keipes, M., Castellarin, A., Rogulja-Pepeonik, Z. and Fuller, J. H. (1998) Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet 351, 28-31
25. Nguyen, Q. D., Brown, D. M., Marcus, D. M., Boyer, D. S., Patel, S., Feiner, L., Gibson, A., Sy, J., Rundle, A. C., Hopkins, J. J. et al. (2012) Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology 119, 789-801
26. Romero-Aroca, P. (2010) Targeting the pathophysiology of diabetic macular edema. Diabetes Care 33, 2484-2485
27. Schwartz, J. A., Lantis, II, J. C., Gendics, C., Fuller, A. M., Payne, W. and Ochs, D. (2012) A prospective, non comparative, multicenter study to investigate the effect of cadexomer iodine on bioburden load and other wound characteristics in diabetic foot ulcers. Int. Wound J., doi: 10.1111/j.1742-481X.2012.01109.x
28. Doria, A. (2010) Genetics of diabetes complications. Curr. Diab. Rep. 10, 467-475
29. Cooper, M. E. and El-Osta, A. (2010) Epigenetics: mechanisms and implications for diabetic complications. Circ. Res. 107, 1403-1413
30. El-Osta, A., Brasacchio, D., Yao, D., Pocai, A., Jones, P. L., Roeder, R. G., Cooper, M. E. and Brownlee, M. (2008) Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J. Exp. Med. 205, 2409-2417
31. Giacco, F. and Brownlee, M. (2010) Oxidative stress and diabetic complications. Circ. Res. 107, 1058-1070
32. Villeneuve, L. M. and Natarajan, R. (2010) The role of epigenetics in the pathology of diabetic complications. Am. J. Physiol. Renal Physiol. 299, F14-F25
33. Kadiyala, C. S., Zheng, L., Du, Y., Yohannes, E., Kao, H. Y., Miyagi, M. and Kern, T. S. (2012) Acetylation of retinal histones in diabetes increases inflammatory proteins: effects of minocycline and manipulation of histone acetyltransferase (HAT) and histone deacetylase (HDAC). J. Biol. Chem. 287, 25869-25880
34. Stitt, A., Gardiner, T. A., Alderson, N. L., Canning, P., Frizzell, N., Duffy, N., Boyle, C., Januszewski, A. S., Chachich, M., Baynes, J. W. and Thorpe, S. R. (2002) The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 51, 2826-2832
35. Kern, T. S. and Engerman, R. L. (1995) Vascular lesions in diabetes are distributed non-uniformly within the retina. Exp. Eye Res. 60, 545-549
36. Kern, T. S. and Engerman, R. L. (1996) A mouse model of diabetic retinopathy. Arch. Ophthalmol. 114, 986-990
37. Engerman, R. L. and Kern, T. S. (1995) Retinopathy in animal models of diabetes. Diabetes Metab. Rev. 11, 109-120
38. Gardiner, T. A., Archer, D. B., Curtis, T. M. and Stitt, A. W. (2007) Arteriolar involvement in the microvascular lesions of diabetic retinopathy: implications for pathogenesis. Microcirculation 14, 25-38
39. Stitt, A. W., Anderson, H. R., Gardiner, T. A. and Archer, D. B. (1994) Diabetic retinopathy: quantitative variation in capillary basement membrane thickening in arterial or venous environments. Br. J. Ophthalmol. 78, 133-137
40. Ljubimov, A. V., Burgeson, R. E., Butkowski, R. J., Couchman, J. R., Zardi, L., Ninomiya, Y., Sado, Y., Huang, Z. S., Nesburn, A. B. and Kenney, M. C. (1996) Basement membrane abnormalities in human eyes with diabetic retinopathy. J. Histochem. Cytochem. 44, 1469-1479
41. Roy, S., Maiello, M. and Lorenzi, M. (1994) Increased expression of basement membrane collagen in human diabetic retinopathy. J. Clin. Invest. 93, 438-442
42. Beltramo, E., Pomero, F., Allione, A., D'Alu, F., Ponte, E. and Porta, M. (2002) Pericyte adhesion is impaired on extracellular matrix produced by endothelial cells in high hexose concentrations. Diabetologia 45, 416-419
43. Padayatti, P. S., Jiang, C., Glomb, M. A., Uchida, K. and Nagaraj, R. H. (2001) High concentrations of glucose induce synthesis of argpyrimidine in retinal endothelial cells. Curr. Eye Res. 23, 106-115
44. Stitt, A. W., Hughes, S. J., Canning, P., Lynch, O., Cox, O., Frizzell, N., Thorpe, S. R., Cotter, T. G., Curtis, T. M. and Gardiner, T. A. (2004) Substrates modified by advanced glycation end-products cause dysfunction and death in retinal pericytes by reducing survival signals mediated by platelet-derived growth factor. Diabetologia 47, 1735-1746
45. Roy, S., Tonkiss, J. and Roy, S. (2010) Aging increases retinal vascular lesions characteristic of early diabetic retinopathy. Biogerontology 11, 447-455
46. Kalfa, T. A., Gerritsen, M. E., Carlson, E. C., Binstock, A. J. and Tsilibary, E. C. (1995) Altered proliferation of retinal microvascular cells on glycated matrix. Invest. Ophthalmol. Visual Sci. 36, 2358-2367
47. Boyd-White, J. and Williams, Jr, J. C. (1996) Effect of cross-linking on matrix permeability. A model for AGE-modified basement membranes. Diabetes 45, 348-353
48. Mott, J. D., Khalifah, R. G., Nagase, H., Shield, III, C. F., Hudson, J. K. and Hudson, B. G. (1997) Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility. Kidney Int. 52, 1302-1312
49. Gardiner, T. A., Anderson, H. R. and Stitt, A. W. (2003) Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes. J. Pathol. 201, 328-333
50. Gardiner, T. A., Stitt, A. W., Anderson, H. R. and Archer, D. B. (1994) Selective loss of vascular smooth muscle cells in the retinal microcirculation of diabetic dogs. Br. J. Ophthalmol. 78, 54-60
51. Mizutani, M., Kern, T. S. and Lorenzi, M. (1996) Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J. Clin.Invest. 97, 2883-2890
52. Hayflick, L. (1965) The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37, 614-636
53. Linskens, M. H., Harley, C. B., West, M. D., Campisi, J. and Hayflick, L. (1995) Replicative senescence and cell death. Science 267, 17
54. Chen, J., Brodsky, S. V., Goligorsky, D. M., Hampel, D. J., Li, H., Gross, S. S. and Goligorsky, M. S. (2002) Glycated collagen I induces premature senescence-like phenotypic changes in endothelial cells. Circ. Res. 90, 1290-1298
55. Khan, Z. A., Farhangkhoee, H. and Chakrabarti, S. (2006) Towards newer molecular targets for chronic diabetic complications. Curr. Vasc. Pharmacol. 4, 45-57
56. Fruttiger, M. (2002) Development of the mouse retinal vasculature: angiogenesis versus vasculogenesis. Invest. Ophthalmol. Visual Sci. 43, 522-527
57. Hoffmann, J., Feng, Y., vom Hagen, F., Hillenbrand, A., Lin, J., Erber, R., Vajkoczy, P., Gourzoulidou, E., Waldmann, H., Giannis, A. et al. (2005) Endothelial survival factors and spatial completion, but not pericyte coverage of retinal capillaries determine vessel plasticity. FASEB J. 19, 2035-2036
58. Cox, O., Stitt, A. W., Simpson, D. A. and Gardiner, T. A. (2003) Sources of PDGF expression in murine retina and the effect of short-term diabetes. Mol. Vision 10, 665-672
59. Hammes, H. P., Lin, J., Renner, O., Shani, M., Lundqvist, A., Betsholtz, C., Brownlee, M. and Deutsch, U. (2002) Pericytes and the pathogenesis of diabetic retinopathy. Diabetes 51, 3107-3112
60. Kohner, E. M. and Dollery, C. T. (1970) Fluorescein angiography of the fundus in diabetic retinopathy. Br. Med. Bull. 26, 166-170
61. Kohner, E. M. and Henkind, P. (1970) Correlation of fluorescein angiogram and retinal digest in diabetic retinopathy. Am. J. Ophthalmol. 69, 403-414
62. Bresnick, G. H., Davis, M. D., Myers, F. L. and de Venecia, G. (1977) Clinicopathologic correlations in diabetic retinopathy. II. Clinical and histologic appearances of retinal capillary microaneurysms. Arch. Ophthalmol. 95, 1215-1220
63. Amemiya, T. and Bhutto, I. A. (2001) Retinal vascular changes and systemic diseases: corrosion cast demonstration. Ital. J. Anat. Embryol. 106, 237-244
64. Baskin, E., Balkanci, F., Cekirge, S., Sener, C. and Saatci, U. (1999) Renal vascular abnormalities in Bardet-Biedl syndrome. Pediatr. Nephrol. 13, 787-789
65. Ishikawa, K., Uyama, M. and Asayama, K. (1983) Occlusive thromboaortopathy (Takayasu's disease): cervical arterial stenoses, retinal arterial pressure, retinal microaneurysms and prognosis. Stroke 14, 730-735
66. Tolentino, M. J., Miller, J. W., Gragoudas, E. S., Jakobiec, F. A., Flynn, E., Chatzistefanou, K., Ferrara, N. and Adamis, A. P. (1996) Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 103, 1820-1828
67. Stitt, A. W., Gardiner, T. A. and Archer, D. B. (1995) Histological and ultrastructural investigation of retinal microaneurysm development in diabetic patients. Br. J. Ophthalmol. 79, 362-367
68. Yanoff, M. (1966) Diabetic retinopathy. N. Engl. J. Med. 274, 1344-1349
69. Miyamoto, K., Khosrof, S., Bursell, S. E., Rohan, R., Murata, T., Clermont, A. C., Aiello, L. P., Ogura, Y. and Adamis, A. P. (1999) Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc. Natl. Acad. Sci. U.S.A. 96, 10836-10841
70. Antonetti, D. A., Barber, A. J., Bronson, S. K., Freeman, W. M., Gardner, T. W., Jefferson, L. S., Kester, M., Kimball, S. R., Krady, J. K., LaNoue, K. F. et al. (2006) Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 55, 2401-2411
71. Roy, M. S., Gunkel, R. D. and Podgor, M. J. (1986) Color vision defects in early diabetic retinopathy. Arch. Ophthalmol. 104, 225-228
72. Sokol, S., Moskowitz, A., Skarf, B., Evans, R., Molitch, M. and Senior, B. (1985) Contrast sensitivity in diabetics with and without background retinopathy. Arch. Ophthalmol. 103, 51-54
73. Yonemura, D., Aoki, T. and Tsuzuki, K. (1962) Electroretinogram in diabetic retinopathy. Arch. Ophthalmol. 68, 19-24
74. Barber, A. J., Lieth, E., Khin, S. A., Antonetti, D. A., Buchanan, A. G. and Gardner, T. W. (1998) Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J. Clin. Invest 102, 783-791
75. Gastinger, M. J., Singh, R. S. and Barber, A. J. (2006) Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas. Invest. Ophthalmol. Visual Sci. 47, 3143-3150
76. Martin, P. M., Roon, P., Van Ells, T. K., Ganapathy, V. and Smith, S. B. (2004) Death of retinal neurons in streptozotocin-induced diabetic mice. Invest. Ophthalmol. Visual Sci. 45, 3330-3336
77. Park, S. H., Park, J. W., Park, S. J., Kim, K. Y., Chung, J. W., Chun, M. H. and Oh, S. J. (2003) Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina. Diabetologia 46, 1260-1268
78. Phipps, J. A., Fletcher, E. L. and Vingrys, A. J. (2004) Paired-flash identification of rod and cone dysfunction in the diabetic rat. Invest. Ophthalmol. Visual Sci. 45, 4592-4600
79. Mizutani, M., Gerhardinger, C. and Lorenzi, M. (1998) Muller cell changes in human diabetic retinopathy. Diabetes 47, 445-449
80. Puro, D. G. (2002) Diabetes-induced dysfunction of retinal Muller cells. Trans. Am. Ophthalmol. Soc. 100, 339-352
81. Lieth, E., Barber, A. J., Xu, B., Dice, C., Ratz, M. J., Tanase, D. and Strother, J. M. (1998) Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Diabetes 47, 815-820
82. Brownlee, M. (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813-820
83. Hammes, H. P., Du, X., Edelstein, D., Taguchi, T., Matsumura, T., Ju, Q., Lin, J., Bierhaus, A., Nawroth, P., Hannak, D. et al. (2003) Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat. Med. 9, 294-299
84. Alkhalaf, A., Kleefstra, N., Groenier, K. H., Bilo, H. J., Gans, R. O., Heeringa, P., Scheijen, J. L., Schalkwijk, C. G., Navis, G. J. and Bakker, S. J. (2012) Effect of benfotiamine on advanced glycation endproducts and markers of endothelial dysfunction and inflammation in diabetic nephropathy. PLoS ONE 7, e40427
85. Fraser, D. A., Diep, L. M., Hovden, I. A., Nilsen, K. B., Sveen, K. A., Seljeflot, I. and Hanssen, K. F. (2012) The effects of long-term oral benfotiamine supplementation on peripheral nerve function and inflammatory markers in patients with type 1 diabetes: a 24-month, double-blind, randomized, placebo-controlled trial. Diabetes Care 35, 1095-1097
86. Kohner, E. M., Patel, V. and Rassam, S. M. (1995) Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes 44, 603-607
87. Delaey, C., Boussery, K. and Van, d.V. (2000) A retinal-derived relaxing factor mediates the hypoxic vasodilation of retinal arteries. Invest. Ophthalmol. Visual Sci. 41, 3555-3560
88. Wagener, H. P., Story, D. T. D. and Wilder, R. M. (1934) Retinitis in diabetes. N. Engl. J. Med. 211, 1131-1137
89. Ballantyne, A. J. and Loewenstein, A. (1943) The pathology of diabetic retinopathy. Trans. Ophthalmol. Soc. 63, 95-113
90. Skovborg, F., Nielsen, A. V., Lauritzen, E. and Hartkopp, O. (1969) Diameters of the retinal vessels in diabetic and normal subjects. Diabetes 18, 292-298
91. Kohner, E. M., Hamilton, A. M., Saunders, S. J., Sutcliffe, B. A. and Bulpitt, C. J. (1975) The retinal blood flow in diabetes. Diabetologia 11, 27-33
92. Kohner, E. M. (1993) The retinal blood flow in diabetes. Diabetes Metab. 19, 401-404
93. Bursell, S. E., Clermont, A. C., Kinsley, B. T., Simonson, D. C., Aiello, L. M. and Wolpert, H. A. (1996) Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy. Invest. Ophthalmol. Visual Sci. 37, 886-897
94. Clermont, A. C., Aiello, L. P., Mori, F., Aiello, L. M. and Bursell, S. E. (1997) Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy. Am. J. Ophthalmol. 124, 433-446
95. Clermont, A. C., Brittis, M., Shiba, T., McGovern, T., King, G. L. and Bursell, S. E. (1994) Normalization of retinal blood flow in diabetic rats with primary intervention using insulin pumps. Invest. Ophthalmol. Visual Sci. 35, 981-990
96. Cunha-Vaz, J. G., Fonseca, J. R., de Abreu, J. R. and Lima, J. J. (1978) Studies on retinal blood flow. II. Diabetic retinopathy. Arch. Ophthalmol. 96, 809-811
97. Yoshida, A., Feke, G. T., Morales-Stoppello, J., Collas, G. D., Goger, D. G. and McMeel, J. W. (1983) Retinal blood flow alterations during progression of diabetic retinopathy. Arch. Ophthalmol. 101, 225-227
98. Ciulla, T. A., Harris, A., Latkany, P., Piper, H. C., Arend, O., Garzozi, H. and Martin, B. (2002) Ocular perfusion abnormalities in diabetes. Acta Ophthalmol. Scand. 80, 468-477
99. Klein, R., Klein, B. E., Moss, S. E., Wong, T. Y., Hubbard, L., Cruickshanks, K. J. and Palta, M. (2003) Retinal vascular abnormalities in persons with type 1 diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVIII. Ophthalmology 110, 2118-2125
100. Schmetterer, L. and Wolzt, M. (1999) Ocular blood flow and associated functional deviations in diabetic retinopathy. Diabetologia 42, 387-405
101. Klein, R., Myers, C. E., Lee, K. E., Gangnon, R. and Klein, B. E. (2012) Changes in retinal vessel diameter and incidence and progression of diabetic retinopathy. Arch Ophthalmol 130, 749-755
102. Grunwald, J. E., Riva, C. E., Baine, J. and Brucker, A. J. (1992) Total retinal volumetric blood flow rate in diabetic patients with poor glycemic control. Invest Ophthalmol.Visual Sci. 33, 356-363
103. Tang, J. and Kern, T. S. (2011) Inflammation in diabetic retinopathy. Prog. Retin. Eye Res. 30, 343-358
104. Joussen, A. M., Poulaki, V., Le, M. L., Koizumi, K., Esser, C., Janicki, H., Schraermeyer, U., Kociok, N., Fauser, S., Kirchhof, B. et al. (2004) A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 18, 1450-1452
105. Talahalli, R., Zarini, S., Tang, J., Li, G., Murphy, R., Kern, T. S. and Gubitosi-Klug, R. A. (2013) Leukocytes regulate retinal capillary degeneration in the diabetic mouse via generation of leukotrienes. J. Leukocyte Biol. 93, 135-143
106. Li, G., Veenstra, A. A., Talahalli, R. R., Wang, X., Gubitosi-Klug, R. A., Sheibani, N. and Kern, T. S. (2012) Marrow-derived cells regulate the development of early diabetic retinopathy and tactile allodynia in mice. Diabetes 61, 3294-3303
107. Gerhardinger, C., Dagher, Z., Sebastiani, P., Park, Y. S. and Lorenzi, M. (2009) The transforming growth factor-ß pathway is a common target of drugs that prevent experimental diabetic retinopathy. Diabetes 58, 1659-1667
108. Brucklacher, R. M., Patel, K. M., Vanguilder, H. D., Bixler, G. V., Barber, A. J., Antonetti, D. A., Lin, C. M., Lanoue, K. F., Gardner, T. W., Bronson, S. K. and Freeman, W. M. (2008) Whole genome assessment of the retinal response to diabetes reveals a progressive neurovascular inflammatory response. BMC Med. Genomics 1, 26
109. Zeng, H. Y., Green, W. R. and Tso, M. O. (2008) Microglial activation in human diabetic retinopathy. Arch. Ophthalmol. 126, 227-232
110. Budzynski, E., Wangsa-Wirawan, N., Padnick-Silver, L., Hatchell, D. and Linsenmeier, R. (2005) Intraretinal pH in diabetic cats. Curr. Eye Res. 30, 229-240
111. Kuiper, E. J., Witmer, A. N., Klaassen, I., Oliver, N., Goldschmeding, R. and Schlingemann, R. O. (2004) Differential expression of connective tissue growth factor in microglia and pericytes in the human diabetic retina. Br. J. Ophthalmol. 88, 1082-1087
112. Xu, H., Chen, M. and Forrester, J. V. (2009) Para-inflammation in the aging retina. Prog. Retin. Eye Res. 28, 348-368
113. Barber, A. J., Antonetti, D. A., Kern, T. S., Reiter, C. E., Soans, R. S., Krady, J. K., Levison, S. W., Gardner, T. W. and Bronson, S. K. (2005) The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest. Ophthalmol. Visual Sci. 46, 2210-2218
114. Rungger-Brandle, E., Dosso, A. A. and Leuenberger, P. M. (2000) Glial reactivity, an early feature of diabetic retinopathy. Invest. Ophthalmol. Visual Sci. 41, 1971-1980
115. Zeng, X. X., Ng, Y. K. and Ling, E. A. (2000) Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats. Visual Neurosci. 17, 463-471
116. Zong, H., Ward, M. and Stitt, A. W. (2011) AGEs, RAGE, and diabetic retinopathy. Curr. Diabetes Rep. 11, 244-252
117. Barile, G. R., Pachydaki, S. I., Tari, S. R., Lee, S. E., Donmoyer, C. M., Ma, W., Rong, L. L., Buciarelli, L. G., Wendt, T., Horig, H. et al. (2005) The RAGE axis in early diabetic retinopathy. Invest. Ophthalmol. Visual Sci. 46, 2916-2924
118. Donato, R. (2001) S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 33, 637-668
119. Zong, H., Ward, M., Madden, A., Yong, P. H., Limb, G. A., Curtis, T. M. and Stitt, A. W. (2010) Hyperglycaemia-induced pro-inflammatory responses by retinal Muller glia are regulated by the receptor for advanced glycation end-products (RAGE). Diabetologia 53, 2656-2666
120. Moore, T. C., Moore, J. E., Kaji, Y., Frizzell, N., Usui, T., Poulaki, V., Campbell, I. L., Stitt, A. W., Gardiner, T. A., Archer, D. B. and Adamis, A. P. (2003) The role of advanced glycation end products in retinal microvascular leukostasis. Invest. Ophthalmol. Visual Sci. 44, 4457-4464
121. Li, G., Tang, J., Du, Y., Lee, C. A. and Kern, T. S. (2011) Beneficial effects of a novel RAGE inhibitor on early diabetic retinopathy and tactile allodynia. Mol. Vision 17, 3156-3165
122. Erickson, K. K., Sundstrom, J. M. and Antonetti, D. A. (2007) Vascular permeability in ocular disease and the role of tight junctions. Angiogenesis. 10, 103-117
123. Trick, G. L., Edwards, P. A., Desai, U., Morton, P. E., Latif, Z. and Berkowitz, B. A. (2008) MRI retinovascular studies in humans: research in patients with diabetes. NMR Biomed. 21, 1003-1012
124. Trick, G. L., Liggett, J., Levy, J., Adamsons, I., Edwards, P., Desai, U., Tofts, P. S. and Berkowitz, B. A. (2005) Dynamic contrast enhanced MRI in patients with diabetic macular edema: initial results. Exp. Eye Res 81, 97-102
125. Simo, R., Villarroel, M., Corraliza, L., Hernandez, C. and Garcia-Ramirez, M. (2010) The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier: implications for the pathogenesis of diabetic retinopathy. J. Biomed. Biotechnol. 2010, 190724
126. Xu, H. Z. and Le, Y. Z. (2011) Significance of outer blood-retina barrier breakdown in diabetes and ischemia. Invest. Ophthalmol. Visual Sci. 52, 2160-2164
127. Krugel, K., Wurm, A., Pannicke, T., Hollborn, M., Karl, A., Wiedemann, P., Reichenbach, A., Kohen, L. and Bringmann, A. (2011) Involvement of oxidative stress and mitochondrial dysfunction in the osmotic swelling of retinal glial cells from diabetic rats. Exp. Eye Res. 92, 87-93
128. Schram, M. T., Chaturvedi, N., Schalkwijk, C., Giorgino, F., Ebeling, P., Fuller, J. H. and Stehouwer, C. D. (2003) Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care 26, 2165-2173
129. Chowdhury, T. A., Hopkins, D., Dodson, P. M. and Vafidis, G. C. (2002) The role of serum lipids in exudative diabetic maculopathy: is there a place for lipid lowering therapy?. Eye 16, 689-693
130. Aiello, L. P., Edwards, A. R., Beck, R. W., Bressler, N. M., Davis, M. D., Ferris, F., Glassman, A. R., Ip, M. S. and Miller, K. M (2010) Factors associated with improvement and worsening of visual acuity 2 years after focal/grid photocoagulation for diabetic macular edema. Ophthalmology 117, 946-953
131. Elman, M. J., Aiello, L. P., Beck, R. W., Bressler, N. M., Bressler, S. B., Edwards, A. R., Ferris, III, F. L., Friedman, S. M., Glassman, A. R., Miller, K. M. et al. (2010) Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 117, 1064-1077
132. Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A. and Park, J. E. (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med. 331, 1480-1487
133. Sone, H., Kawakami, Y., Okuda, Y., Sekine, Y., Honmura, S., Matsuo, K., Segawa, T., Suzuki, H. and Yamashita, K. (1997) Ocular vascular endothelial growth factor levels in diabetic rats are elevated before observable retinal proliferative changes. Diabetologia 40, 726-730
134. Lip, P. L., Belgore, F., Blann, A. D., Hope-Ross, M. W., Gibson, J. M. and Lip, G. Y. (2000) Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment. Invest. Ophthalmol. Visual Sci. 41, 2115-2119
135. Beck, R. W., Edwards, A. R., Aiello, L. P., Bressler, N. M., Ferris, F., Glassman, A. R., Hartnett, E., Ip, M. S., Kim, J. E. and Kollman, C. (2009) Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch. Ophthalmol. 127, 245-251
136. Mitchell, P., Bandello, F., Schmidt-Erfurth, U., Lang, G. E., Massin, P., Schlingemann, R. O., Sutter, F., Simader, C., Burian, G., Gerstner, O., Weichselberger, A. and group, R. s. (2011) The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 118, 615-625
137. Nguyen, Q. D., Shah, S. M., Khwaja, A. A., Channa, R., Hatef, E., Do, D. V., Boyer, D., Heier, J. S., Abraham, P., Thach, A. B. et al. (2010) Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. Ophthalmology 117, 2146-2151
138. Abedi, F., Wickremasinghe, S., Richardson, A. J., Makalic, E., Schmidt, D. F., Sandhu, S. S., Baird, P. N. and Guymer, R. H. (2013) Variants in the VEGFA gene and treatment outcome after anti-VEGF treatment for neovascular age-related macular degeneration. Ophthalmology, 120, 115-121
139. Nguyen, Q. D., Shah, S. M., Heier, J. S., Do, D. V., Lim, J., Boyer, D., Abraham, P., Campochiaro, P. A. and Group, R.-S. (2009) Primary end point (six months): results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study. Ophthalmology 116, 2175-2181
140. Massin, P., Bandello, F., Garweg, J. G., Hansen, L. L., Harding, S. P., Larsen, M., Mitchell, P., Sharp, D., Wolf-Schnurrbusch, U. E., Gekkieva, M., Weichselberger, A. and Wolf, S. (2010) Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care 33, 2399-2405
141. Michaelides, M., Kaines, A., Hamilton, R. D., Fraser-Bell, S., Rajendram, R., Quhill, F., Boos, C. J., Xing, W., Egan, C., Peto, T. et al. (2010) A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2. Ophthalmology 117, 1078-1086
142. Do, D. V., Schmidt-Erfurth, U., Gonzalez, V. H., Gordon, C. M., Tolentino, M., Berliner, A. J., Vitti, R., Ruckert, R., Sandbrink, R., Stein, D. et al. (2011) The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema. Ophthalmology 118, 1819-1826
143. Dewan, V., Lambert, D., Edler, J., Kymes, S. and Apte, R. S. (2012) Cost-effectiveness analysis of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 119, 1679-1684
144. Haller, J. A., Kuppermann, B. D., Blumenkranz, M. S., Williams, G. A., Weinberg, D. V., Chou, C. and Whitcup, S. M. (2010) Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. Arch. Ophthalmol. 128, 289-296
145. Campochiaro, P. A., Brown, D. M., Pearson, A., Ciulla, T., Boyer, D., Holz, F. G., Tolentino, M., Gupta, A., Duarte, L., Madreperla, S. et al. (2011) Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema. Ophthalmology 118, 626-635
146. Arrigg, P. G. and Cavallerano, J. (1998) The role of vitrectomy for diabetic retinopathy. J. Am. Optom. Assoc. 69, 733-740
147. Keech, A. C., Mitchell, P., Summanen, P. A., O'Day, J., Davis, T. M., Moffitt, M. S., Taskinen, M. R., Simes, R. J., Tse, D., Williamson, E. et al. (2007) Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet 370, 1687-1697
148. Spranger, J., Mohlig, M., Osterhoff, M., Buhnen, J., Blum, W. F. and Pfeiffer, A. F. (2001) Retinal photocoagulation does not influence intraocular levels of IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy-evidence for combined treatment of PDR with somatostatin analogues and retinal photocoagulation? Horm. Metab. Res. 33, 312-316
149. Campochiaro, P. A., Hafiz, G., Channa, R., Shah, S. M., Nguyen, Q. D., Ying, H., Do, D. V., Zimmer-Galler, I., Solomon, S. D., Sung, J. U. and Syed, B. (2010) Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomes. Ophthalmology 117, 2387-2394
150. Benjamin, LE, Hemo, I and E, K. (1998) A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125, 1591-1598
151. Nishijima, K., Ng, Y. S., Zhong, L., Bradley, J., Schubert, W., Jo, N., Akita, J., Samuelsson, S. J., Robinson, G. S., Adamis, A. P. and Shima, D. T. (2007) Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am. J. Pathol. 171, 53-67
152. Saint-Geniez, M. and D'Amore, P. A. (2004) Development and pathology of the hyaloid, choroidal and retinal vasculature. Int. J. Dev. Biol. 48, 1045-1058
153. Saint-Geniez, M., Maharaj, A. S., Walshe, T. E., Tucker, B. A., Sekiyama, E., Kurihara, T., Darland, D. C., Young, M. J. and D'Amore, P. A. (2008) Endogenous VEGF is required for visual function: evidence for a survival role on muller cells and photoreceptors. PLoS ONE 3, e3554
154. D'Amore, P. A. (2007) Vascular endothelial cell growth factor-A: not just for endothelial cells anymore. Am. J. Pathol. 171, 14-18
155. Chung, E. J., Freeman, W. R. and Koh, H. J. (2008) Visual acuity and multifocal electroretinographic changes after arteriovenous crossing sheathotomy for macular edema associated with branch retinal vein occlusion. Retina 28, 220-225
156. Chung, E. J., Hong, Y. T., Lee, S. C., Kwon, O. W. and Koh, H. J. (2008) Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion. Graefes Arch. Clin. Exp. Ophthalmol. 246, 1241-1247
157. Kim, L. A. and D'Amore, P. A. (2012) A brief history of anti-VEGF for the treatment of ocular angiogenesis. Am. J. Pathol. 181, 376-379
158. Goven, D., Boutten, A., Lecon-Malas, V., Marchal-Somme, J., Amara, N., Crestani, B., Fournier, M., Leseche, G., Soler, P., Boczkowski, J. and Bonay, M. (2008) Altered Nrf2/Keap1-Bach1 equilibrium in pulmonary emphysema. Thorax 63, 916-924
159. Malhotra, D., Thimmulappa, R., Navas-Acien, A., Sandford, A., Elliott, M., Singh, A., Chen, L., Zhuang, X., Hogg, J., Pare, P. et al. (2008) Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1. Am. J. Respir. Crit. Care Med. 178, 592-604
160. Malhotra, D., Thimmulappa, R., Vij, N., Navas-Acien, A., Sussan, T., Merali, S., Zhang, L., Kelsen, S. G., Myers, A., Wise, R. et al. (2009) Heightened endoplasmic reticulum stress in the lungs of patients with chronic obstructive pulmonary disease: the role of Nrf2-regulated proteasomal activity. Am. J. Respir. Crit. Care Med 180, 1196-1207
161. Suzuki, M., Betsuyaku, T., Ito, Y., Nagai, K., Nasuhara, Y., Kaga, K., Kondo, S. and Nishimura, M. (2008) Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol. 39, 673-682
162. Pergola, P. E., Krauth, M., Huff, J. W., Ferguson, D. A., Ruiz, S., Meyer, C. J. and Warnock, D. G. (2011) Effect of bardoxolone methyl on kidney function in patients with T2D and Stage 3b-4 CKD. Am. J. Nephrol. 33, 469-476
163. Kowluru, R. A. and Zhong, Q. (2011) Beyond AREDS: is there a place for antioxidant therapy in the prevention/treatment of eye disease? Invest. Ophthalmol. Visual Sci. 52, 8665-8671
164. Ellis, E. A., Grant, M. B., Murray, F. T., Wachowski, M. B., Guberski, D. L., Kubilis, P. S. and Lutty, G. A. (1998) Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat. Free Radical Biol. Med. 24, 111-120
165. Ellis, E. A., Guberski, D. L., Somogyi-Mann, M. and Grant, M. B. (2000) Increased H2O2, vascular endothelial growth factor and receptors in the retina of the BBZ/Wor diabetic rat. Free Radical Biol. Med. 28, 91-101
166. Ellis, E. A., Guberski, D. L., Hutson, B. and Grant, M. B. (2002) Time course of NADH oxidase, inducible nitric oxide synthase and peroxynitrite in diabetic retinopathy in the BBZ/WOR rat. Nitric Oxide 6, 295-304
167. Chen, P., Guo, A. M., Edwards, P. A., Trick, G. and Scicli, A. G. (2007) Role of NADPH oxidase and ANG II in diabetes-induced retinal leukostasis. Am. J. Physiol. Regul. Integ. Comp. Physiol. 293, R1619-R1629
168. Al-Shabrawey, M., Rojas, M., Sanders, T., Behzadian, A., El-Remessy, A., Bartoli, M., Parpia, A. K., Liou, G. and Caldwell, R. B. (2008) Role of NADPH oxidase in retinal vascular inflammation. Invest. Ophthalmol. Visual Sci. 49, 3239-3244
169. Gao, B. B., Clermont, A., Rook, S., Fonda, S. J., Srinivasan, V. J., Wojtkowski, M., Fujimoto, J. G., Avery, R. L., Arrigg, P. G., Bursell, S. E. et al. (2007) Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. Nat. Med. 13, 181-188
170. Giusti, C., Forte, R., Vingolo, E. M. and Gargiulo, P. (2001) Is acetazolamide effective in the treatment of diabetic macular edema? A pilot study. Int. Ophthalmol. 24, 79-88
171. Kita, T., Clermont, A. C., Fujisawa, K., Ishibashi, T., Aiello, L. P. and Feener, E. P. (2012) Identification of a VEGF-independent and plasma kallikrein-kinin-dependent pathway of retinal vascular permeability in diabetic macular edema. Invest. Ophthalmol. Visual Sci. 2431, A526
172. Carmeliet, P. (2004) Manipulating angiogenesis in medicine. J. Intern. Med. 255, 538-561
173. Smith, L. E., Wesolowski, E., McLellan, A., Kostyk, S. K., D'Amato, R., Sullivan, R. and D'Amore, P. A. (1994) Oxygen-induced retinopathy in the mouse. Invest. Ophthalmol. Visual Sci. 35, 101-111
174. Stitt, A. W., McKenna, D., Simpson, D. A., Gardiner, T. A., Harriott, P., Archer, D. B. and Nelson, J. (1998) The 67-kd laminin receptor is preferentially expressed by proliferating retinal vessels in a murine model of ischemic retinopathy. Am. J. Pathol. 152, 1359-1365
175. Donaldson, E. A., McKenna, D. J., McMullen, C. B., Scott, W. N., Stitt, A. W. and Nelson, J. (2000) The expression of membrane-associated 67-kDa laminin receptor (67LR) is modulated in vitro by cell-contact inhibition. Mol. Cell. Biol. Res. Comm. 3, 53-59
176. McKenna, D. J., Simpson, D. A., Feeney, S., Gardiner, T. A., Boyle, C., Nelson, J. and Stitt, A. W. (2001) Expression of the 67 kDa laminin receptor (67LR) during retinal development: correlations with angiogenesis. Exp. Eye Res. 73, 81-92
177. Gardiner, T. A., Gibson, D. S., de Gooyer, T. E., de la Cruz, V. F., McDonald, D. M. and Stitt, A. W. (2005) Inhibition of tumor necrosis factor-a improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy. Am. J. Pathol. 166, 637-644
178. Medina, R. J., O'Neill, C. L., Devine, A. B., Gardiner, T. A. and Stitt, A. W. (2008) The pleiotropic effects of simvastatin on retinal microvascular endothelium has important implications for ischaemic retinopathies. PLoS ONE 3, e2584
179. McVicar, C. M., Colhoun, L. M., Abrahams, J. L., Kitson, C. L., Hamilton, R., Medina, R. J., Durga, D., Gardiner, T. A., Rudd, P. M. and Stitt, A. W. (2010) Differential modulation of angiogenesis by erythropoiesis-stimulating agents in a mouse model of ischaemic retinopathy. PLoS ONE 5, e11870
180. Chen, J., Connor, K. M., Aderman, C. M. and Smith, L. E. (2008) Erythropoietin deficiency decreases vascular stability in mice. J. Clin. Invest. 118, 526-533
181. McVicar, C. M., Hamilton, R., Colhoun, L. M., Gardiner, T. A., Brines, M., Cerami, A. and Stitt, A. W. (2011) Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy. Diabetes 60, 2995-3005
182. Thum, T., Fraccarollo, D., Schultheiss, M., Froese, S., Galuppo, P., Widder, J. D., Tsikas, D., Ertl, G. and Bauersachs, J. (2007) Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes 56, 666-674
183. O'Neill, C. L., O'Doherty, M. T., Wilson, S. E., Rana, A. A., Hirst, C. E., Stitt, A. W. and Medina, R. J. (2012) Therapeutic revascularisation of ischaemic tissue: the opportunities and challenges for therapy using vascular stem/progenitor cells. Stem Cell Res. Ther. 3, 31
184. Hibbert, B., Olsen, S. and O'Brien, E. (2003) Involvement of progenitor cells in vascular repair. Trends Cardiovasc. Med. 13, 322-326
185. Stitt, A. W., O'Neill, C. L., O'Doherty, M. T., Archer, D. B., Gardiner, T. A. and Medina, R. J. (2011) Vascular stem cells and ischaemic retinopathies. Prog. Ret. Eye Res. 30, 149-166
186. Kusuyama, T., Omura, T., Nishiya, D., Enomoto, S., Matsumoto, R., Takeuchi, K., Yoshikawa, J. and Yoshiyama, M. (2006) Effects of treatment for diabetes mellitus on circulating vascular progenitor cells. J. Pharmacol. Sci. 102, 96-102
187. Fadini, G. P., Sartore, S., Albiero, M., Baesso, I., Murphy, E., Menegolo, M., Grego, F., Vigili de Kreutzenberg, S., Tiengo, A., Agostini, C. and Avogaro, A. (2006) Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler. Thromb. Vasc. Biol. 26, 2140-2146
188. Tepper, O. M., Galiano, R. D., Capla, J. M., Kalka, C., Gagne, P. J., Jacobowitz, G. R., Levine, J. P. and Gurtner, G. C. (2002) Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106, 2781-2786
189. Ingram, D. A., Lien, I. Z., Mead, L. E., Estes, M., Prater, D. N., Derr-Yellin, E., DiMeglio, L. A. and Haneline, L. S. (2008) In vitro hyperglycemia or a diabetic intrauterine environment reduces neonatal endothelial colony-forming cell numbers and function. Diabetes 57, 724-731
190. Loomans, C. J., de Koning, E. J., Staal, F. J., Rookmaaker, M. B., Verseyden, C., de Boer, H. C., Verhaar, M. C., Braam, B., Rabelink, T. J. and van Zonneveld, A. J. (2004) Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53, 195-199
191. Egan, C. G., Lavery, R., Caporali, F., Fondelli, C., Laghi-Pasini, F., Dotta, F. and Sorrentino, V. (2008) Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes. Diabetologia 51, 1296-1305
192. Shantsila, E., Watson, T. and Lip, G. Y. (2007) Endothelial progenitor cells in cardiovascular disorders. J. Am. Coll. Cardiol. 49, 741-752
193. Grant, M. B., May, W. S., Caballero, S., Brown, G. A., Guthrie, S. M., Mames, R. N., Byrne, B. J., Vaught, T., Spoerri, P. E., Peck, A. B. and Scott, E. W. (2002) Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat. Med. 8, 607-612
194. Dorrell, M. I., Otani, A., Aguilar, E., Moreno, S. K. and Friedlander, M. (2004) Adult bone marrow-derived stem cells use R-cadherin to target sites of neovascularization in the developing retina. Blood 103, 3420-3427
195. Caballero, S., Sengupta, N., Afzal, A., Chang, K. H., Li Calzi, S., Guberski, D. L., Kern, T. S. and Grant, M. B. (2007) Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells. Diabetes 56, 960-967
196. Medina, R. J., O'Neill, C. L., Humphreys, M. W., Gardiner, T. A. and Stitt, A. W. (2010) Outgrowth endothelial cells: characterization and their potential for reversing ischemic retinopathy. Invest. Ophthalmol. Visual Sci. 51, 5906-5913
197. Medina, R. J., O'Neill, C. L., O'Doherty, T. M., Knott, H., Guduric-Fuchs, J., Gardiner, T. A. and Stitt, A. W. (2011) Myeloid angiogenic cells act as alternative M2 macrophages and modulate angiogenesis through interleukin-8. Mol. Med. 17, 1045-1055
198. Otani, A., Kinder, K., Ewalt, K., Otero, F. J., Schimmel, P. and Friedlander, M. (2002) Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat. Med. 8, 1004-1010
199. Awad, O., Jiao, C., Ma, N., Dunnwald, M. and Schatteman, G. C. (2005) Obese diabetic mouse environment differentially affects primitive and monocytic endothelial cell progenitors. Stem Cells 23, 575-583
200. Crisan, M., Yap, S., Casteilla, L., Chen, C. W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L. et al. (2008) A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3, 301-313
201. Quevedo, H. C., Hatzistergos, K. E., Oskouei, B. N., Feigenbaum, G. S., Rodriguez, J. E., Valdes, D., Pattany, P. M., Zambrano, J. P., Hu, Q., McNiece, I. et al. (2009) Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc. Natl. Acad. Sci. U.S.A. 106, 14022-14027
202. Dar, A., Domev, H., Ben-Yosef, O., Tzukerman, M., Zeevi-Levin, N., Novak, A., Germanguz, I., Amit, M. and Itskovitz-Eldor, J. (2012) Multipotent vasculogenic pericytes from human pluripotent stem cells promote recovery of murine ischemic limb. Circulation 125, 87-99
203. Katare, R., Riu, F., Mitchell, K., Gubernator, M., Campagnolo, P., Cui, Y., Fortunato, O., Avolio, E., Cesselli, D., Beltrami, A. P. et al. (2011) Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132. Circ. Res. 109, 894-906